Skip Navigation


Hum. Reprod. Advance Access originally published online on June 13, 2007
Human Reproduction 2007 22(8):2196-2201; doi:10.1093/humrep/dem153
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
22/8/2196    most recent
dem153v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Vieira, C.S.
Right arrow Articles by Silva-de-Sá, M.F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vieira, C.S.
Right arrow Articles by Silva-de-Sá, M.F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Use of the etonogestrel-releasing implant is associated with hypoactivation of the coagulation cascade

C.S. Vieira1,4, R.A. Ferriani1, A.A. Garcia2, M.C. Pintão2, G.D. Azevedo3, M.K.O. Gomes1 and M.F. Silva-de-Sá1

1 Department of Gynaecology and Obstetrics, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto, Brazil 2 Department of Haemostasis, Hospital das Clínicas, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto, Brazil 3 Federal University of Rio Grande do Norte, Natal, Brazil

4 Correspondence address. Tel: +55-16-3602-2804; Fax: +55-16-3633-0946; E-mail: carol.sales{at}uol.com.br

BACKGROUND: The role of progestogens in haemostasis is controversial. Our objective is to evaluate the haemostatic effects of an etonogestrel-releasing implant.

METHODS: This open-label, self-controlled, longitudinal study involved 20 healthy women receiving subcutaneous etonogestrel-releasing implants. At baseline, 1, 3 and 6 months, we measured the following: activated partial thromboplastin time; prothrombin time; thrombin time; fibrinogen; coagulation factors II, V, VII, VIII, IX, X and XI; von Willebrand factor; activated protein C (APC); antithrombin; free protein S; plasminogen activator inhibitor type 1 (PAI-1); {alpha}2-antiplasmin; thrombin–antithrombin (TAT) complex; prothrombin fragment 1 + 2 (F1 + 2); D-dimers; APC resistance. Statistical analyses included the Friedman test and ANOVA.

RESULTS: Levels of APC (P < 0.01), factor II (P = 0.02), factor VII (P = 0.006), factor X (P = 0.01) and F1 + 2 (P < 0.001) were reduced, whereas those of PAI-1 (P = 0.01) and factor XI (P = 0.006) were transitory increased. All of these values, however, remained within normal ranges. Surprisingly, TAT concentrations fell below the normal range (P < 0.001).

CONCLUSIONS: Our findings suggest that the etonogestrel-releasing implant does not induce a prothrombotic pattern during the first six months of use, and that its use is associated with a reduction in thrombin generation.

Key words: etonogestrel/progestogens/haemostasis/coagulation/contraception

Submitted on January 16, 2007; resubmitted on May 4, 2007; accepted on May 9, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.